Tag: equity
-
Infusion-to-Oral Drug Delivery Company Acquired
A company with a technology for converting drugs given by intravenous infusion into pills and capsules was acquired Grünenthal Group, a provider of pain medications.
-
Fertility Device Company Gains $9.7M in Early Funds
A two year-old medical device enterprise making a fertility tracker for women is raising $9.7 million in its first venture finance round.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Institutes, Companies Form Business to Bridge Discovery Gap
Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials.
-
3-D Printing Creates Heart-on-Chip with Sensors
Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing.
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
Gene Silencing Treatments Licensed for Heart Disease
Biopharmaceutical company Amgen is acquiring the rights to a technology that stops the actions of inherited genes associated with a leading type of heart disease.
-
Harvard Spin-Off to Sequence, Visualize RNA in Tissue
A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue.